Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports

INTRODUCTION: Vortioxetine, a multimodal serotonergic drug, is widely used as treatment for major depressive disorder. Although on the market since late 2013, the data of the relative safety of vortioxetine, especially compared to selective serotonin reuptake inhibitors, are still scarce. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekhart, Corine, van Hunsel, Florence, van Puijenbroek, Eugène, Chandler, Rebecca, Meldau, Eva-Lisa, Taavola, Henric, Norén, G. Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857005/
https://www.ncbi.nlm.nih.gov/pubmed/35020178
http://dx.doi.org/10.1007/s40264-021-01139-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857005/
https://www.ncbi.nlm.nih.gov/pubmed/35020178
http://dx.doi.org/10.1007/s40264-021-01139-y

Ejemplares similares